Suppr超能文献

根据国际小儿肿瘤学会(SIOP)2001方案治疗的IV期完全坏死性肾母细胞瘤和局部III期的治疗结果。

Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol.

作者信息

Dávila Fajardo Raquel, Furtwängler Rhoikos, van Grotel Martine, van Tinteren Harm, Pasqualini Claudia, Pritchard-Jones Kathy, Al-Saadi Reem, de Camargo Beatriz, Ramírez Villar Gema L, Graf Norbert, Muracciole Xavier, Melchior Patrick, Saunders Daniel, Rübe Christian, van den Heuvel-Eibrink Marry M, Janssens Geert O, Verschuur Arnauld C

机构信息

Department of Radiation Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

出版信息

Cancers (Basel). 2021 Feb 26;13(5):976. doi: 10.3390/cancers13050976.

Abstract

OBJECTIVE

Wilms tumour (WT) patients with a localised completely necrotic nephroblastoma after preoperative chemotherapy are a favourable outcome group. Since the introduction of the SIOP 2001 protocol, the SIOP- Renal Tumour Study Group (SIOP-RTSG) has omitted radiotherapy for such patients with low-risk, local stage III in an attempt to reduce treatment burden. However, for metastatic patients with local stage III, completely necrotic WT, the recommendations led to ambiguous use. The purpose of this descriptive study is to demonstrate the outcomes of patients with metastatic, completely necrotic and local stage III WT in relation to the application of radiotherapy or not.

METHODS AND MATERIALS

all metastatic patients with local stage III, completely necrotic WT after 6 weeks of preoperative chemotherapy who were registered in the SIOP 2001 study were included in this analysis. The pattern of recurrence according to the usage of radiation treatment and 5 year event-free survival (EFS) and overall survival (OS) was analysed.

RESULTS

seven hundred and three metastatic WT patients were registered in the SIOP 2001 database. Of them, 47 patients had a completely necrotic, local stage III WT: 45 lung metastases (11 combined localisations), 1 liver/peritoneal, and 1 tumour thrombus in the renal vein and the inferior vena cava with bilateral pulmonary arterial embolism. Abdominal radiotherapy was administered in 29 patients (62%; 29 flank/abdominal irradiation and 9 combined with lung irradiation). Eighteen patients did not receive radiotherapy. Median follow-up was 6.6 years (range 1-151 months). Two of the 47 patients (4%) developed disease recurrence in the lung (one combined with abdominal relapse) and eventually died of the disease. Both patients had received abdominal radiotherapy, one of them combined with lung irradiation. Five-year EFS and OS were 95% and 95%, respectively.

CONCLUSIONS

the outcome of patients with stage IV, local stage III, completely necrotic Wilms tumours is excellent. Our results suggest that abdominal irradiation in this patient category may not be of added value in first-line treatment, consistent with the current recommendation in the SIOP-RTSG 2016 UMBRELLA protocol.

摘要

目的

术前化疗后患有局限性完全坏死性肾母细胞瘤的肾母细胞瘤(WT)患者是预后良好的一组。自SIOP 2001方案引入以来,SIOP肾肿瘤研究组(SIOP-RTSG)已省略对这类低风险、局部III期患者的放疗,以试图减轻治疗负担。然而,对于局部III期、完全坏死的转移性WT患者,这些建议导致了使用上的不明确。本描述性研究的目的是证明局部III期、转移性、完全坏死的WT患者接受或不接受放疗的结果。

方法和材料

纳入SIOP 2001研究中登记的所有术前化疗6周后患有局部III期、完全坏死的转移性WT患者。分析根据放疗使用情况的复发模式以及5年无事件生存率(EFS)和总生存率(OS)。

结果

703例转移性WT患者登记在SIOP 2001数据库中。其中,47例患者患有完全坏死的局部III期WT:45例肺转移(11例合并其他部位转移),1例肝/腹膜转移,1例肾静脉和下腔静脉肿瘤血栓伴双侧肺动脉栓塞。29例患者(62%)接受了腹部放疗(29例进行侧腹/腹部照射,9例联合肺部照射)。18例患者未接受放疗。中位随访时间为6.6年(范围1-151个月)。47例患者中有2例(4%)出现肺部疾病复发(1例合并腹部复发),最终死于该疾病。这两名患者均接受了腹部放疗,其中1例联合肺部照射。5年EFS和OS分别为95%和95%。

结论

IV期、局部III期、完全坏死的肾母细胞瘤患者的预后极佳。我们的结果表明,在这类患者的一线治疗中,腹部照射可能没有附加价值,这与SIOP-RTSG 2016伞式方案中的当前建议一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9558/7956604/bbf53a4cf14e/cancers-13-00976-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验